Skip to content
  • Argentina
  • Brazil
  • Canada
  • Chile
  • Colombia
  • Europe
  • France
  • Germany
  • India
  • Italy
  • Japan
  • Korea
  • Mexico
  • Perú
  • Russia
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
  • Vietnam
  • Country/Region
    • Clinic Portal
      • +0034963905310
    • Request Information
    • +34 96 390 53 10
    • Part of brands: |
    InternationalInternational
    • Country/Region
      • Part of brands: |
      • We guide you
        • Fertility
          • What to do if…
        • Prevent Inherited Diseases
          • Carrier Genetic Test
        • Worry-free Pregnancy
          • NACE
          • Prenatal Diagnostics
          • Newborn Health
      • Reproductive Health
        • Specialists
          • ALICE
          • EMMA
          • ERA
          • EndomeTRIO
          • EMBRACE
          • CGT
          • NACE
          • Zenit
          • PGT-A
          • PGT-M
          • POC
          • SAT
          • Newborn Screening
        • Patients
          • ALICE
          • EMMA
          • ERA
          • EndomeTRIO
          • EMBRACE
          • CGT
          • NACE
          • Zenit
          • PGT-A
          • PGT-M
          • SAT
          • POC
      • Diagnostics
      • About us
        • Igenomix Research
        • About Igenomix
        • Igenomix Worldwide
      • Academy
      • Blog
      Genomics Precision Diagnostic > Rheumatology Precision Panel > Juvenile Idiopathic Arthritis Precision Panel

      Juvenile Idiopathic Arthritis Precision Panel

      Juvenile arthritis is a heterogenous group of inflammatory arthritis of unknown etiology, all defined by the presence of at least one inflamed joint persisting more than six weeks.
      Rheumatology
      Overview
      Indication
      Clinical Utility
      Genes & Diseases
      Methodology
      References

      Overview

      • Juvenile arthritis is a heterogenous group of inflammatory arthritis of unknown etiology, all defined by the presence of at least one inflamed joint persisting more than six weeks. Juvenile Idiopathic Arthritis (JIA) is the most common rheumatic disease in children, with an unpredictable clinical course and the impending risk of impaired joint function. It begins before 16 years of age, and the triggering factor can be a trauma or infection. JIA can be classified in six categories:  

        Systemic arthritis 
        Polyarthritis (rheumatoid factor positive or negative) 
        Oligoarthritis 
        Enthesitis-related arthritis 
        Psoriatic arthritis 
        Undifferentiated arthritis 

      • The prognosis varies depending on the case, but systemic arthritis and rheumatoid factor positive polyarthritis generally show a worse prognosis. The most common mode of inheritance is autosomal recessive.  

      • The Igenomix Juvenile Idiopathic Arthritis Precision Panel can be used to make an accurate and directed diagnosis as well as a differential diagnosis of arthritis ultimately leading to a better management and prognosis of the disease. It provides a comprehensive analysis of the genes involved in this disease using next-generation sequencing (NGS) to fully understand the spectrum of relevant genes involved.  

      Indication

      • The Igenomix Juvenile Idiopathic Arthritis Precision Panel is indicated for those patients with a clinical diagnosis or suspicion presenting with or without the following manifestations: 
        • Arthralgias 
        • Rash 
        • Fever 
        • Lymphadenopathy 
        • Arthritis 
        • Pericarditis 

      Clinical Utility

      The clinical utility of this panel is: 

      • The genetic and molecular confirmation for an accurate clinical diagnosis of a symptomatic patient.    
      • Early initiation of multidisciplinary treatment including occupational and physical therapist, pharmacologic treatment with anti-inflammatory drugs to reduce pain and swelling, or even disease-modifying antirheumatic drugs (DMARDs) if there is a high risk of damage in the future. 
      • Risk assessment and genetic counselling of asymptomatic family members according to the mode of inheritance. 
      • Improvement of delineation of genotype-phenotype correlation. 

      Genes & Diseases

      Methodology

      References

      See scientific referrals

      Prakken, B., Albani, S., & Martini, A. (2011). Juvenile idiopathic arthritis. Lancet (London, England), 377(9783), 2138–2149. 

      Smolen, J. S., Landewé, R., Bijlsma, J., Burmester, G. R., Dougados, M., Kerschbaumer, A., McInnes, I. B., Sepriano, A., van Vollenhoven, R. F., de Wit, M., Aletaha, D., Aringer, M., Askling, J., Balsa, A., Boers, M., den Broeder, A. A., Buch, M. H., Buttgereit, F., Caporali, R., Cardiel, M. H., … van der Heijde, D. (2020). EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Annals of the rheumatic diseases, 79(6), 685–699. 

      Siegel, P., Tencza, M., Apodaca, B., & Poole, J. L. (2017). Effectiveness of Occupational Therapy Interventions for Adults With Rheumatoid Arthritis: A Systematic Review. The American journal of occupational therapy: official publication of the American Occupational Therapy Association, 71(1), 7101180050p1–7101180050p11. 

      Thatayatikom, A., & De Leucio, A. (2020). Juvenile Idiopathic Arthritis. In StatPearls. StatPearls Publishing. 

      Eng, S. W., Duong, T. T., Rosenberg, A. M., Morris, Q., Yeung, R. S., & REACCH OUT and BBOP Research Consortia (2014). The biologic basis of clinical heterogeneity in juvenile idiopathic arthritis. Arthritis & rheumatology (Hoboken, N.J.), 66(12), 3463–3475. 

      descargar

      Detail description

      Download

      Request Information


      WE GUIDE YOU

      Fertility
      Inherited diseases prevention
      Healthy pregnancy

      To see the accreditation certificate, associated technical annex and list of accredited tests, click on this link.

      OUR SERVICES

      Genetic solutions
      For patients
      How to send a sample?
      User manual

      ABOUT US

      About Igenomix
      Contact
      Quality
      Complaints
      Work with us

      FOLLOW IGENOMIX

        + 96 390 53 10
        Write us
      • Argentina
      • Brazil
      • Canada
      • Chile
      • Colombia
      • Europe
      • France
      • Germany
      • India
      • Italy
      • Japan
      • Korea
      • Mexico
      • Perú
      • Russia
      • Spain
      • Taiwan
      • The Middle East
      • Turkey
      • United Kingdom
      • United States
      • Vietnam
      Country/Region

      [2021] © Igenomix Privacy policy Quality policy Legal note Cookies policyNews and Press

      Request Information

















      • We guide you
        • Fertility
          • What to do if…
        • Prevent Inherited Diseases
          • Carrier Genetic Test
        • Worry-free Pregnancy
          • NACE
          • Prenatal Diagnostics
          • Newborn Health
      • Reproductive Health
        • Specialists
          • ALICE
          • EMMA
          • ERA
          • EndomeTRIO
          • EMBRACE
          • CGT
          • NACE
          • Zenit
          • PGT-A
          • PGT-M
          • POC
          • SAT
          • Newborn Screening
        • Patients
          • ALICE
          • EMMA
          • ERA
          • EndomeTRIO
          • EMBRACE
          • CGT
          • NACE
          • Zenit
          • PGT-A
          • PGT-M
          • SAT
          • POC
      • Diagnostics
      • About us
        • Igenomix Research
        • About Igenomix
        • Igenomix Worldwide
      • Academy
      • Blog
      • Country/Region
      • +34 96 390 53 10
      • Clinic Portal
      • Request Information

      We are using cookies to give you the best experience on our website.

      You can find out more about which cookies we are using or switch them off in settings.

      International
      Powered by  GDPR Cookie Compliance
      Privacy Overview

      This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

      Strictly Necessary Cookies

      Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

      If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

      3rd Party Cookies

      This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

      Keeping this cookie enabled helps us to improve our website.

      Please enable Strictly Necessary Cookies first so that we can save your preferences!

      Cookie Policy

      More information about our Cookie Policy